Abstract
Recent studies have powerfully demonstrated that women with depression, whether treated with SSRIs or skip treatment, report double risk of cardiovascular malformations. Yet, physicians and epidemiologists continue to terrify women who are at serious life threatening risks if not treated pharmacologically, with non evidence-based information. This paper calls for immediate stop of such practice.
| Original language | English |
|---|---|
| Pages (from-to) | e369-e370 |
| Journal | Journal of Population Therapeutics and Clinical Pharmacology |
| Volume | 19 |
| Issue number | 3 |
| State | Published - 2012 |
| Externally published | Yes |
Keywords
- Drug therapy
- Maternal depression
- Pregnancy
- Risk